Symmetry Investments’s Labcorp LH Stock Holding History

Symmetry Investments’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,317	Closed	-$299K	–	226
2023 Q4	$299K	Buy	+1,317	New	+$277K	0.02%	176

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Symmetry Investments's LH Position: Q1 2024 in Review

Symmetry Investments sold out of Labcorp (LH) in Q1 2024, closing a stake of 1,317 shares — an estimated $299K sold.

Symmetry Investments first reported a position in LH in Q4 2023 and held it in 1 quarter. The position peaked at $299K in Q4 2023. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

Symmetry Investments reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
Symmetry Investments sold 1,317 Labcorp shares in Q1 2024, an estimated $299K.
Symmetry Investments first reported a position in Labcorp in Q4 2023 and held it in 1 quarter.
Symmetry Investments's Labcorp position peaked at $299K in Q4 2023.
927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Symmetry Investments's 13F filing for Q1 2024, filed 10 May 2024.